ReviewIranian biomedical journal2025
Neuroprotective Potential of Ocimum sanctum Polyphenols: Mechanisms and Therapeutic Implications.
Review in Iranian biomedical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodegenerative diseases are major global health concerns due to progressive neuronal deterioration. Natural compounds, particularly plant polyphenols, are being explored for their neuroprotective potential. O. sanctum (Holy Basil or Tulsi) polyphenols, which possess pharmacological activities, were emphasized in this review. O. sanctum contains flavonoids, phenolic acids, and tannins, which exhibit strong antioxidant activity through scavenging free radicals and boosting endogenous antioxidants. These compounds also demonstrate anti-inflammatory activities, modulate cytokine production, and increase synaptic plasticity. Their anti-apoptotic effects inhibit the degeneration of neuronal cells. Preclinical studies demonstrated potential neuroprotective effects of O. sanctum polyphenols in different NDD models, with a few clinical studies suggesting their safety and efficacy over conventional neuroprotective medicines. Elucidating these mechanisms could help the development of O. sanctum polyphenols as drugs to combat NDDs and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.